p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1)

被引:182
|
作者
King, CC
Gardiner, EMM
Zenke, FT
Bohl, BP
Newton, AC
Hemmings, BA
Bokoch, GM
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[2] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA
[3] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA
[4] Friedrich Miescher Inst, CH-4002 Basel, Switzerland
关键词
D O I
10.1074/jbc.M006553200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we show that phosphorylated 3-phosphoinositide-dependent kinase 1 (PDK1) phosphorylates pal-activated kinase 1 (PAK1) in the presence of sphingosine. We identify threonine 423, a conserved threonine in the activation loop of kinase subdomain VIII, as the PDK1 phosphorylation site on PAK1. Threonine 423 is a previously identified PAK1 autophosphorylation site that lies within a PAK consensus phosphorylation sequence. After pretreatment with phosphatases, autophosphorylation of PAK1 occurred at all major sites except threonine 423. A phosphothreonine 423-specific antibody detected phosphorylation of recombinant, catalytically inactive PAK1 after incubation with wild-type PAK1, indicating phosphorylation of threonine 423 occurs by an intermolecular mechanism. The biological significance of PDK1 phosphorylation of PAK1 at threonine 423 in vitro is supported by the observation that these two proteins interact in vivo and that PDK1-phosphorylated PAK1 has an increased activity toward substrate. An increase of phosphorylation of catalytically inactive PAK1 was observed in COS-7 cells expressing wild-type, but not catalytically inactive, PDK1 upon elevation of intracellular sphingosine levels. PDK1 phosphorylation of PAK1 was not blocked by pretreatment with wortmannin or when PDK1 was mutated to prevent phosphatidylinositol binding, indicating this process is independent of phosphatidylinositol 3-kinase activity. The data presented here provide evidence for a novel mechanism for PAK1 regulation and activation.
引用
收藏
页码:41201 / 41209
页数:9
相关论文
共 50 条
  • [1] p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity
    Guo, Ping
    Liu, Yufeng
    Feng, Jingrong
    Tang, Shihang
    Wei, Fanyan
    Feng, Jian
    ARCHIVES OF TOXICOLOGY, 2022, 96 (12) : 3143 - 3162
  • [2] p21-activated kinase 1 (PAK1) as a therapeutic target for cardiotoxicity
    Ping Guo
    Yufeng Liu
    Jingrong Feng
    Shihang Tang
    Fanyan Wei
    Jian Feng
    Archives of Toxicology, 2022, 96 : 3143 - 3162
  • [3] p21-Activated kinase 1 (PAK1) in aging and longevity: An overview
    Amirthalingam, Mohankumar
    Palanisamy, Sundararaj
    Tawata, Shinkichi
    AGEING RESEARCH REVIEWS, 2021, 71
  • [4] Dissecting the role of the 3-phosphoinositide-dependent protein kinase-1 (PDK1) signalling pathways
    Bayascas, Jose R.
    CELL CYCLE, 2008, 7 (19) : 2978 - 2982
  • [5] Involvement of p21-Activated Kinase-1 (PAK1) in Glucotoxicity-Induced β-Cell Apoptosis
    Zhang, Jiping
    Li, Guodong
    DIABETES, 2009, 58 : A403 - A403
  • [6] Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes
    Ke, YB
    Wang, L
    Pyle, WG
    de Tombe, PP
    Solaro, RJ
    CIRCULATION RESEARCH, 2004, 94 (02) : 194 - 200
  • [7] 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases
    Xie, Zhihui
    Yuan, Hongyan
    Yin, Yuzhi
    Zeng, Xiao
    Bai, Renkui
    Glazer, Robert I.
    BMC CANCER, 2006, 6 (1)
  • [8] Discovery of potent and kinase-selective p21-activated kinase 1 (PAK1) inhibitors
    Rudolph, Joachim
    Aliagas, Ignacio
    Blackwood, Elizabeth
    O'Brien, Thomas
    Crawford, James
    Drobnick, Joy
    Gazzard, Lewis
    Heise, Christopher
    Lee, Wendy
    Murray, Lesley
    Ndubaku, Chudi
    Wang, Weiru
    Zhao, Xianrui
    Hoeflich, Klaus
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [9] 3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases
    Zhihui Xie
    Hongyan Yuan
    Yuzhi Yin
    Xiao Zeng
    Renkui Bai
    Robert I Glazer
    BMC Cancer, 6
  • [10] Selective 3-Phosphoinositide-Dependent Kinase 1 (PDK1) Inhibitors: Dissecting the Function and Pharmacology of PDK1
    Medina, Jesus R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (07) : 2726 - 2737